Last reviewed · How we verify
ETHER
ETHER is a marketed homeopathic preparation primarily indicated for the relief of irregular bowel habits. Its key strength lies in its unique mechanism of action based on the principle of 'like cures like,' which differentiates it from conventional treatments. The primary risk is the key composition patent expiry in 2028, which could lead to increased competition from generic homeopathic products.
At a glance
| Generic name | ETHER |
|---|---|
| Drug class | Standardized Chemical Allergen [EPC] |
| Target | Not specified |
| Modality | Small molecule |
| Therapeutic area | Gastroenterology |
| Phase | FDA-approved |
Approved indications
- Relief of irregular bowel habits
- Relief of nausea
- Relief of difficulty sleeping
- Relief of fatigue
- Relief of minor aches of muscles and joints
Common side effects
Key clinical trials
- Total Intravenous and Balanced Anesthesia in Diabetic Patients Undergoing Video-Assisted Thoracoscopy (PHASE4)
- Non-Invasive Programmed Stimulation (NIPS) to Guide the Subsequent VT Therapeutic Strategies (NA)
- pAF for the Treatment of Osteoarthritis (PHASE1, PHASE2)
- Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing Surgery (PHASE1)
- Propofol Versus Sevoflurane Anesthesia on the Intraocular Pressure and Hemodynamics in Patient Undergoing Cyclophotocoagulation (NA)
- A Post-market-clinical Follow-up Investigation of Safety and Performance by Decoria® Voluma (NA)
- Efficacy and Safety of Inhaled Isoflurane Delivered Via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensive Care Unit Adult Patients (INSPiRE-ICU2) (PHASE3)
- Case-Control Study of Pesticides and Childhood Leukemia
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ETHER CI brief — competitive landscape report
- ETHER updates RSS · CI watch RSS